Advertisement

Topics

Vical Provides Company Update at Biocom's Global Life Science Partnering Conference

19:00 EST 23 Feb 2017 | Globe Newswire

SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 2:15 p.m. PT on Thursday, March 2, at Biocom's Global Life Science Partnering Conference (La Jolla – March  1-2). A copy of the presentation will be available through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.

About Vical
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.

Contact:
Tony Ramos
(858) 646-1127
Website: www.vical.com

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Vical Provides Company Update at Biocom's Global Life Science Partnering Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...